These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Methodological problems of using platelet MAO in psychiatric research. Demisch L; Kaczmarczyk P; Gebhart P Mod Probl Pharmacopsychiatry; 1983; 19():265-77. PubMed ID: 6865968 [No Abstract] [Full Text] [Related]
13. [Decrease in the thrombocyte monoamine oxidase activity of schizophrenic patients]. Kurilova II; Lideman RR Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(9):1351-4. PubMed ID: 706910 [TBL] [Abstract][Full Text] [Related]
15. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates. Baron M; Perumal AS; Levitt M; Cannova G Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713 [No Abstract] [Full Text] [Related]
16. Human platelet monoamine oxidase activity in health and disease: a review. Sandler M; Reveley MA; Glover V J Clin Pathol; 1981 Mar; 34(3):292-302. PubMed ID: 6453137 [TBL] [Abstract][Full Text] [Related]
17. Platelet MAO activity and high risk for psychopathology in a German population. Propping P; Friedl W Mod Probl Pharmacopsychiatry; 1983; 19():304-14. PubMed ID: 6865970 [No Abstract] [Full Text] [Related]
18. Intracellular distribution of monoamine oxidase, 5-hydroxytryptamine and histamine in blood platelets of rabbit. Solatunturi E; Paasonen MK Ann Med Exp Biol Fenn; 1966; 44(3):427-30. PubMed ID: 5958861 [No Abstract] [Full Text] [Related]
19. Mixture distributions in psychiatric research. Gibbons RD; Dorus E; Ostrow DG; Pandey GN; Davis JM; Levy DL Biol Psychiatry; 1984 Jul; 19(7):935-61. PubMed ID: 6477998 [TBL] [Abstract][Full Text] [Related]